Chaput Nathalie相关文献与解析，生知库 | 链接生命科学的每一步

Ma, Yuting; Aymeric, Laetitia; Locher, Clara; Mattarollo, Stephen R; Delahaye, Nicolas F; Pereira, Pablo; Boucontet, Laurent; Apetoh, Lionel; Ghiringhelli, François; Casares, Noëlia; Lasarte, Juan José; Matsuzaki, Goro; Ikuta, Koichi; Ryffel, Bernard; Benlagha, Kamel; Tesnière, Antoine; Ibrahim, Nicolas; Déchanet-Merville, Julie; Chaput, Nathalie; Smyth, Mark J; Kroemer, Guido; Zitvogel, Laurence

肿瘤

T细胞

肿瘤免疫

Increased IFN responses drive myeloid cell activation in people living with HIV-1.

HIV-1感染者体内IFN反应增强，导致髓系细胞活化

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-04613-0

PlaÃ§ais LÃ©o, Joly Candie, d'Urbano Vanessa, Paolini Annamaria, Bitu Marie, Mouanga Christelliah, Bourdic Katia, Desjardins Delphine, Bredel Delphine, Bourdic Katia, Chaput Nathalie, Jacquelin BÃ©atrice, MÃ¼ller-TrÃ¼twin Michaela, Bourgeois Christine, Lambotte Olivier, Noel Nicolas

细胞生物学

发表日期：2025

文献求助收藏

Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines

IMID患者体内扩增的衰老CD8 T细胞与特定的炎症细胞因子相关

期刊:Clinical and Experimental Immunology

影响因子:3.8

doi:10.1093/cei/uxaf050

Naigeon, Marie; Bitoun, Samuel; Roulleaux Dugage, Matthieu; de Oliveira, Caroline; Berthot, Caroline; Besse, Benjamin; Marabelle, Aurélien; Danlos, François-Xavier; Mariette, Xavier; Chaput, Nathalie; Nocturne, Gaetane

B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors

B细胞与实体瘤患者免疫检查点抑制剂反应的协调

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2023-008636

Flippot, Ronan; Teixeira, Marcus; Rey-Cardenas, Macarena; Carril-Ajuria, Lucia; Rainho, Larissa; Naoun, Natacha; Jouniaux, Jean-Mehdi; Boselli, Lisa; Naigeon, Marie; Danlos, Francois-Xavier; Escudier, Bernard; Scoazec, Jean-Yves; Cassard, Lydie; Albiges, Laurence; Chaput, Nathalie

Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma

基于血液的循环生物标志物用于预测肾细胞癌中免疫检查点抑制剂的疗效

期刊:Exploration of Targeted Antitumor Therapy

影响因子:

doi:10.37349/etat.2024.00271

Omri, Loubna; Naigeon, Marie; Flippot, Ronan; Gavira-Díaz, Javier; Poveda-Ferriols, Jesus; Nguyen, Dan; Abdi, Chaimae; Arroyo-Salgado, Alvaro; Chaput, Nathalie; de Velasco, Guillermo; Albigès, Laurence; Carril-Ajuria, Lucía

Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?

针对免疫检查点的抗体：剂量和给药方案优化的空间？

期刊:Journal of Hematology & Oncology

影响因子:40.4

doi:10.1186/s13045-021-01182-3

Maritaz, Christophe; Broutin, Sophie; Chaput, Nathalie; Marabelle, Aurélien; Paci, Angelo

免疫/内分泌

发表日期：2022

文献求助收藏

CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

CD8(+)PD-1(+) 与 CD4(+)PD-1(+) 比值 (PERLS) 与接受 PD-(L)1 阻滞剂治疗的晚期非小细胞肺癌患者的预后相关

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2021-004012

Duchemann, Boris; Naigeon, Marie; Auclin, Edouard; Ferrara, Roberto; Cassard, Lydie; Jouniaux, Jean-Mehdi; Boselli, Lisa; Grivel, Jonathan; Desnoyer, Aude; Danlos, François-Xavier; Mezquita, Laura; Caramella, Caroline; Marabelle, Aurelien; Besse, Benjamin; Chaput, Nathalie

Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer

非小细胞肺癌免疫治疗疗效的现有和未来生物标志物

期刊:Translational Lung Cancer Research

影响因子:3.5

doi:10.21037/tlcr-20-839

Duchemann, Boris; Remon, Jordi; Naigeon, Marie; Cassard, Lydie; Jouniaux, Jean Mehdi; Boselli, Lisa; Grivel, Jonathan; Auclin, Edouard; Desnoyer, Aude; Besse, Benjamin; Chaput, Nathalie

IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment

IL-15 超激动剂 RLI 对 NK 细胞具有强大的免疫刺激作用：对转移治疗的意义

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2020-000632

Desbois, Mélanie; Béal, Coralie; Charrier, Mélinda; Besse, Benjamin; Meurice, Guillaume; Cagnard, Nicolas; Jacques, Yannick; Béchard, David; Cassard, Lydie; Chaput, Nathalie

Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer

将循环生物标志物整合到肺癌免疫检查点抑制剂治疗中

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers12123625

Duchemann, Boris; Remon, Jordi; Naigeon, Marie; Mezquita, Laura; Ferrara, Roberto; Cassard, Lydie; Jouniaux, Jean Mehdi; Boselli, Lisa; Grivel, Jonathan; Auclin, Edouard; Desnoyer, Aude; Besse, Benjamin; Chaput, Nathalie

Correction: Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy

更正：IL-17 产生 γδ T 细胞对抗癌化疗疗效的贡献

Increased IFN responses drive myeloid cell activation in people living with HIV-1.

HIV-1感染者体内IFN反应增强，导致髓系细胞活化

Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines

IMID患者体内扩增的衰老CD8 T细胞与特定的炎症细胞因子相关

B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors

B细胞与实体瘤患者免疫检查点抑制剂反应的协调

Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma

基于血液的循环生物标志物用于预测肾细胞癌中免疫检查点抑制剂的疗效

Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?

针对免疫检查点的抗体：剂量和给药方案优化的空间？

CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

CD8(+)PD-1(+) 与 CD4(+)PD-1(+) 比值 (PERLS) 与接受 PD-(L)1 阻滞剂治疗的晚期非小细胞肺癌患者的预后相关

Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer

非小细胞肺癌免疫治疗疗效的现有和未来生物标志物

IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment

IL-15 超激动剂 RLI 对 NK 细胞具有强大的免疫刺激作用：对转移治疗的意义

Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer

将循环生物标志物整合到肺癌免疫检查点抑制剂治疗中